» Articles » PMID: 14744815

EP4 Prostanoid Receptor-mediated Vasodilatation of Human Middle Cerebral Arteries

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2004 Jan 28
PMID 14744815
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

1. Dilatation of the cerebral vasculature is recognised to be involved in the pathophysiology of migraine. Furthermore, elevated levels of prostaglandin E(2) (PGE(2)) occur in the blood, plasma and saliva of migraineurs during an attack, suggestive of a contributory role. In the present study, we have characterised the prostanoid receptors involved in the relaxation and contraction of human middle cerebral arteries in vitro. 2. In the presence of indomethacin (3 microm) and the TP receptor antagonist GR32191 (1 microM), PGE(2) was found to relax phenylephrine precontracted cerebral arterial rings in a concentration-dependent manner (mean pEC(50) 8.0+/-0.1, n=5). 3. Establishment of a rank order of potency using the EP(4)>EP(2) agonist 11-deoxy PGE(1), and the EP(2)>EP(4) agonist PGE(1)-OH (mean pEC(50) of 7.6+/-0.1 (n=6) and 6.4+/-0.1 (n=4), respectively), suggested the presence of functional EP(4) receptors. Furthermore, the selective EP(2) receptor agonist butaprost at concentrations <1 microM failed to relax the tissues. 4. Blockade of EP(4) receptors with the EP(4) receptor antagonists AH23848 and EP(4)A caused significant rightward displacements in PGE(2) concentration-response curves, exhibiting pA(2) and pK(B) values of 5.7+/-0.1, n=3, and 8.4, n=3, respectively. 5. The IP receptor agonists iloprost and cicaprost relaxed phenylephrine precontracted cerebral arterial rings (mean pEC(50) values 8.3+/-0.1 (n=4) and 8.1+/-0.1 (n=9), respectively). In contrast, the DP and FP receptor agonists PGD(2) and PGF(2 alpha) failed to cause appreciable relaxation or contraction at concentrations of up to 30 microm. In the absence of phenylephrine contraction and GR32191, the TP receptor agonist U46619 caused concentration-dependent contraction of cerebral artery (mean pEC(50) 7.4+/-0.3, n=3). 6. These data demonstrate the presence of prostanoid EP(4) receptors mediating PGE(2) vasodilatation of human middle cerebral artery. IP receptors mediating relaxation and TP receptors mediating contraction were also functionally demonstrated.

Citing Articles

Dissecting the Regulation of Arachidonic Acid Metabolites by (Miq). Miq. in Spontaneously Hypertensive Rats and the Predictive Target sEH in the Anti-Hypertensive Effect Based on Metabolomics and Molecular Docking.

Gao L, Kong X, Wu W, Feng Z, Zhi H, Zhang Z Front Pharmacol. 2022; 13:909631.

PMID: 35712719 PMC: 9196077. DOI: 10.3389/fphar.2022.909631.


Changes in Plasma Lipid Levels Following Cortical Spreading Depolarization in a Transgenic Mouse Model of Familial Hemiplegic Migraine.

Loonen I, Kohler I, Ghorasaini M, Giera M, van den Maagdenberg A, Mayboroda O Metabolites. 2022; 12(3).

PMID: 35323663 PMC: 8953552. DOI: 10.3390/metabo12030220.


What is the relative contribution of biological and psychosocial factors to the generation of hypoxia headache?.

Barbiani D, Camerone E, Benedetti F Can J Pain. 2022; 2(1):160-168.

PMID: 35005376 PMC: 8730614. DOI: 10.1080/24740527.2018.1478224.


Effects of Arachidonic Acid Metabolites on Cardiovascular Health and Disease.

Zhou Y, Khan H, Xiao J, Cheang W Int J Mol Sci. 2021; 22(21).

PMID: 34769460 PMC: 8584625. DOI: 10.3390/ijms222112029.


Neurovascular Coupling in Development and Disease: Focus on Astrocytes.

Stackhouse T, Mishra A Front Cell Dev Biol. 2021; 9:702832.

PMID: 34327206 PMC: 8313501. DOI: 10.3389/fcell.2021.702832.


References
1.
Prior M, Cooper K, May L, Bowen D . Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia. 2002; 22(9):740-8. DOI: 10.1046/j.1468-2982.2002.00419.x. View

2.
Gao I, Scholz P, Boehme M, Norden C, Lemmel E . A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects. Rheumatol Int. 2002; 22(2):45-51. DOI: 10.1007/s00296-002-0187-x. View

3.
Peatfield R, Gawel M, ROSE F . The effect of infused prostacyclin in migraine and cluster headache. Headache. 1981; 21(5):190-5. DOI: 10.1111/j.1526-4610.1981.hed2105190.x. View

4.
Uski T, Andersson K, Brandt L, Edvinsson L, Ljunggren B . Responses of isolated feline and human cerebral arteries to prostacyclin and some of its metabolites. J Cereb Blood Flow Metab. 1983; 3(2):238-45. DOI: 10.1038/jcbfm.1983.32. View

5.
Parantainen J . Prostaglandins in alcohol intolerance and hangover. Drug Alcohol Depend. 1983; 11(3-4):239-48. DOI: 10.1016/0376-8716(83)90016-9. View